Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_assertion type Assertion NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_head.
- NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_assertion description "[In the group of patients with AOD, those who were positive for DRB1*16 specificity have a statistically significant chance to develop EN, as opposed to those who are positive for DRB1*15 specificity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_provenance.
- NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_assertion evidence source_evidence_literature NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_provenance.
- NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_assertion SIO_000772 17767551 NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_provenance.
- NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_assertion wasDerivedFrom befree-2016 NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_provenance.
- NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_assertion wasGeneratedBy ECO_0000203 NP627937.RAx-7NqQH5zuKLYCwBYZH-uWXdoEn0rTGHR2ATw6Eyud4130_provenance.